Want to see HK:2293 full AI Analyst Report?
Bamboos Health Care Holdings Ltd (2293) Ratios
Bamboos Health Care Holdings Ltd Ratios
HK:2293's free cash flow for Q4 2025 was $0.00. For the 2025 fiscal year, HK:2293's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.71 | 0.92 | 1.28 | 1.24 | 1.01 |
| Quick Ratio | 0.70 | 0.91 | 1.27 | 1.22 | 0.99 |
| Cash Ratio | 0.42 | 0.51 | 0.81 | 0.75 | 0.61 |
| Solvency Ratio | 0.11 | 0.31 | 0.41 | 0.46 | 0.47 |
| Operating Cash Flow Ratio | 0.00 | 0.43 | 0.38 | 0.34 | 0.83 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.60 | 0.59 | 0.64 | 1.70 |
| Net Current Asset Value | $ -22.57M | $ -7.85M | $ 28.26M | $ 28.50M | $ 1.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.18 | 0.20 | 0.20 | 0.20 | 0.20 |
| Debt-to-Equity Ratio | 0.24 | 0.27 | 0.29 | 0.31 | 0.33 |
| Debt-to-Capital Ratio | 0.19 | 0.21 | 0.23 | 0.23 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.38 | 1.46 | 1.56 | 1.67 |
| Debt Service Coverage Ratio | 0.21 | 0.46 | 0.67 | 0.86 | 0.97 |
| Interest Coverage Ratio | 0.00 | 6.67 | 12.00 | 25.04 | 61.38 |
| Debt to Market Cap | 0.39 | 0.31 | 0.25 | 0.22 | 0.21 |
| Interest Debt Per Share | 0.15 | 0.16 | 0.17 | 0.18 | 0.18 |
| Net Debt to EBITDA | 1.72 | 0.53 | -0.33 | -0.36 | -0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.36% | 41.66% | 89.38% | 90.96% | 65.10% |
| EBIT Margin | 19.77% | 34.57% | 44.97% | 47.30% | 52.48% |
| EBITDA Margin | 22.93% | 47.01% | 55.66% | 55.19% | 57.96% |
| Operating Profit Margin | 16.45% | 29.53% | 42.96% | 47.30% | 52.15% |
| Pretax Profit Margin | 14.14% | 30.14% | 41.39% | 46.36% | 51.63% |
| Net Profit Margin | 9.35% | 23.58% | 32.62% | 37.07% | 41.78% |
| Continuous Operations Profit Margin | 9.35% | 23.58% | 32.62% | 37.07% | 41.78% |
| Net Income Per EBT | 66.08% | 78.21% | 78.82% | 79.97% | 80.93% |
| EBT Per EBIT | 85.98% | 102.10% | 96.33% | 98.03% | 99.01% |
| Return on Assets (ROA) | 1.92% | 5.55% | 9.72% | 13.53% | 16.68% |
| Return on Equity (ROE) | 2.52% | 7.65% | 14.16% | 21.10% | 27.83% |
| Return on Capital Employed (ROCE) | 4.43% | 9.55% | 18.65% | 26.85% | 34.73% |
| Return on Invested Capital (ROIC) | 2.37% | 5.89% | 11.38% | 16.52% | 21.52% |
| Return on Tangible Assets | 1.92% | 5.55% | 9.72% | 30.33% | 39.62% |
| Earnings Yield | 4.15% | 8.76% | 12.47% | 15.64% | 17.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.74 | 3.31 | 2.39 | 2.71 | 3.12 |
| Payables Turnover | 2.44 | 2.50 | 0.48 | 2.04 | 1.72 |
| Inventory Turnover | 30.50 | 42.68 | 8.49 | 25.80 | 15.76 |
| Fixed Asset Turnover | 0.43 | 0.46 | 0.56 | 0.72 | 0.77 |
| Asset Turnover | 0.21 | 0.24 | 0.30 | 0.36 | 0.40 |
| Working Capital Turnover Ratio | -4.56 | 7.03 | 3.30 | 8.18 | 2.18 |
| Cash Conversion Cycle | -40.28 | -27.24 | -558.99 | -30.46 | -71.86 |
| Days of Sales Outstanding | 97.57 | 110.36 | 152.60 | 134.59 | 116.99 |
| Days of Inventory Outstanding | 11.97 | 8.55 | 42.99 | 14.15 | 23.16 |
| Days of Payables Outstanding | 149.82 | 146.15 | 754.57 | 179.20 | 212.02 |
| Operating Cycle | 109.54 | 118.91 | 195.59 | 148.73 | 140.16 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.09 | 0.09 | 0.10 | 0.29 |
| Free Cash Flow Per Share | 0.00 | 0.09 | 0.09 | 0.10 | 0.25 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 1.68 | 1.02 | 1.19 | 2.08 |
| Capital Expenditure Coverage Ratio | 0.00 | 20.34 | 22.51 | 160.67 | 7.38 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.59 | 0.59 | 0.61 | 1.68 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.50 | 0.39 | 0.33 | 0.83 |
| Free Cash Flow Yield | 0.00% | 17.50% | 14.42% | 13.89% | 30.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.04 | 11.42 | 8.02 | 6.39 | 5.66 |
| Price-to-Sales (P/S) Ratio | 2.25 | 2.69 | 2.62 | 2.37 | 2.37 |
| Price-to-Book (P/B) Ratio | 0.61 | 0.87 | 1.14 | 1.35 | 1.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 5.71 | 6.94 | 7.20 | 3.31 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 5.43 | 6.63 | 7.15 | 2.86 |
| Price-to-Earnings Growth (PEG) Ratio | -0.37 | -0.26 | -0.23 | -0.32 | 0.00 |
| Enterprise Value Multiple | 11.55 | 6.25 | 4.37 | 3.94 | 3.87 |
| Enterprise Value | 176.70M | 218.73M | 230.58M | 274.97M | 314.69M |
| EV to EBITDA | 11.55 | 6.25 | 4.37 | 3.94 | 3.87 |
| EV to Sales | 2.65 | 2.94 | 2.43 | 2.17 | 2.24 |
| EV to Free Cash Flow | 0.00 | 6.24 | 6.45 | 6.60 | 3.14 |
| EV to Operating Cash Flow | 0.00 | 5.94 | 6.16 | 6.56 | 2.71 |
| Tangible Book Value Per Share | 0.62 | 0.57 | 0.55 | 0.44 | 0.41 |
| Shareholders’ Equity Per Share | 0.62 | 0.57 | 0.55 | 0.56 | 0.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | 0.22 | 0.21 | 0.20 | 0.19 |
| Revenue Per Share | 0.17 | 0.19 | 0.24 | 0.32 | 0.35 |
| Net Income Per Share | 0.02 | 0.04 | 0.08 | 0.12 | 0.15 |
| Tax Burden | 0.66 | 0.78 | 0.79 | 0.80 | 0.81 |
| Interest Burden | 0.72 | 0.87 | 0.92 | 0.98 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.13 | 0.04 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.00 | 0.02 |
| Income Quality | 0.00 | 2.10 | 1.21 | 0.89 | 1.98 |
Currency in HKD
